NEW YORK STATE COMMON RETIREMENT FUND - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 214 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2023. The put-call ratio across all filers is 2.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$1,862
-15.8%
37,074
+5.9%
0.00%0.0%
Q2 2023$2,212
+17.3%
34,996
-16.5%
0.00%0.0%
Q1 2023$1,886
-18.1%
41,925
-20.3%
0.00%0.0%
Q4 2022$2,303
-99.9%
52,575
+5.6%
0.00%
-40.0%
Q3 2022$3,280,000
+45.4%
49,779
+11.5%
0.01%
+66.7%
Q2 2022$2,256,000
-30.0%
44,658
-11.5%
0.00%0.0%
Q1 2022$3,225,000
-37.8%
50,478
+4.2%
0.00%
-40.0%
Q4 2021$5,188,000
+3.7%
48,436
-0.5%
0.01%0.0%
Q3 2021$5,003,000
-1.8%
48,662
-16.0%
0.01%0.0%
Q2 2021$5,095,000
-9.6%
57,923
-0.0%
0.01%
-16.7%
Q1 2021$5,634,000
-13.3%
57,9500.0%0.01%
-14.3%
Q4 2020$6,499,000
+20.5%
57,950
-0.4%
0.01%0.0%
Q3 2020$5,395,000
+20.7%
58,200
+1.6%
0.01%
+16.7%
Q2 2020$4,469,000
+57.2%
57,300
+17.9%
0.01%
+50.0%
Q1 2020$2,842,000
-19.2%
48,600
+10.7%
0.00%0.0%
Q4 2019$3,517,000
-6.1%
43,900
-13.9%
0.00%
-20.0%
Q3 2019$3,747,000
-26.9%
51,000
-6.1%
0.01%
-16.7%
Q2 2019$5,123,000
+25.3%
54,312
+6.3%
0.01%
+20.0%
Q1 2019$4,089,000
+86.8%
51,077
+25.8%
0.01%
+66.7%
Q4 2018$2,189,000
-44.0%
40,600
-18.9%
0.00%
-40.0%
Q3 2018$3,910,000
+23.0%
50,0860.0%0.01%
+25.0%
Q2 2018$3,179,000
-37.7%
50,086
-10.0%
0.00%
-33.3%
Q1 2018$5,103,000
+32.6%
55,649
+9.0%
0.01%
+20.0%
Q4 2017$3,848,000
+13.9%
51,034
+5.2%
0.01%
+25.0%
Q3 2017$3,379,000
+49.2%
48,507
+8.6%
0.00%
+33.3%
Q2 2017$2,264,000
+153.0%
44,672
+99.6%
0.00%
+200.0%
Q1 2017$895,000
+55.7%
22,383
+9.2%
0.00%0.0%
Q4 2016$575,000
-5.6%
20,5000.0%0.00%0.0%
Q3 2016$609,000
+46.7%
20,5000.0%0.00%0.0%
Q2 2016$415,000
+123.1%
20,500
+99.0%
0.00%
Q1 2016$186,000
-31.4%
10,3000.0%0.00%
Q4 2015$271,000
+23.2%
10,3000.0%0.00%
Q3 2015$220,000
+36.6%
10,300
+69.1%
0.00%
Q2 2015$161,0006,0910.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders